Utility of the germ tube test for direct identification of Candida albicans from positive blood culture bottles

Journal of Clinical Microbiology

Volumn 46, Issue 10, 2008, Pages 3508-3509

  Sheppard, Donald C ^a   Locas, Marie Claude ^b   Restieri, Christiane ^b   Laverdiere, Michel ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDEMIA; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BLOOD; CANDIDA ALBICANS; CANDIDIASIS; FUNGEMIA; HUMANS; MYCOLOGY; SENSITIVITY AND SPECIFICITY;

CANDIDA ALBICANS;

EID: 53649085247     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01113-08     Document Type: Article

References (10)

1. Forrest, G. N., K. Mankes, M. A. Jabra-Rizk, E. Weekes, J. K. Johnson, D. P. Lincalis, and R. A. Venezia. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J. Clin. Microbiol. 44:3381-3383.
2. Garey, K. W., M. Rege, M. P. Pai, D. E. Mingo, K. J. Suda, R. S. Turpin, and D. T. Bearden. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31.
3. Harrington, A., K. McCourtney, D. Nowowiejski, and A. Limaye. 2007. Differentiation of Candida albicans from non-albicans yeast directly from blood cultures by Gram stain morphology. Eur. J. Clin. Microbiol. Infect. Dis. 26:325-329.
4. Kumar, A., D. Roberts, K. E. Wood, B. Light, J. E. Parrillo, S. Sharma, R. Suppes, D. Feinstein, S. Zanotti, L. Taiberg, D. Gurka, and M. Cheang. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34:1589-1596.
5. Morrell, M., V. J. Fraser, and M. H. Kollef. 2005. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49:3640-3645.
6. Pappas, P. G., J. H. Rex, J. D. Sobel, S. G. Filler, W. E. Dismukes, T. J. Walsh, and J. E. Edwards. 2004. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38:161-189.
7. Pfaller, M. A., D. J. Diekema, R. N. Jones, S. A. Messer, and R. J. Hollis. 2002. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J. Clin. Microbiol. 40:852-856.
8. Selvarangan, R., U. Bui, A. P. Limaye, and B. T. Cookson. 2003. Rapid identification of commonly encountered Candida species directly from blood culture bottles. J. Clin. Microbiol. 41:5660-5664.
9. St-Germain, G., M. Laverdiere, R. Pelletier, P. Rene, A. M. Bourgault, C. Lemieux, and M. Libman. 2008. Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: Report on 453 cases between 2003 and 2005. Can. J. Infect. Dis. Med. Microbiol. 19:55-62.
10. Terlecka, J. A., P. A. du Cros, C. Orla Morrissey, and D. Spelman. 2007. Rapid differentiation of Candida albicans from non-albicans species by germ tube test directly from BacTAlert blood culture bottles. Mycoses 50:48-51.